Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
1996 results about "Formamide" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Formamide, also known as methanamide, is an amide derived from formic acid. It is a clear liquid which is miscible with water and has an ammonia-like odor. It is chemical feedstock for the manufacture of sulfa drugs, other pharmaceuticals, herbicides, pesticides and the manufacture of hydrocyanic acid. It has been used as a softener for paper and fiber. It is a solvent for many ionic compounds. It has also been used as a solvent for resins and plasticizers.
Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
![Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fc68549-2d37-4f83-89dd-f36e605466b3/US07553855-20090630-D00001.png "Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fc68549-2d37-4f83-89dd-f36e605466b3/US07553855-20090630-D00002.png "Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fc68549-2d37-4f83-89dd-f36e605466b3/US07553855-20090630-D00003.png "Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Pharmaceutical composition and administrations thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
Owner:VERTEX PHARMA INC
Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
InactiveUS20110064811A1Improve solubilityGood physical and chemical stabilityBiocidePowder deliveryFormamideOxoquinolines
The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
![Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/a113b4d7-c198-49c0-a9ea-68b5e5fb4c63/US20110064811A1-20110317-D00000.png "Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/a113b4d7-c198-49c0-a9ea-68b5e5fb4c63/US20110064811A1-20110317-D00001.png "Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/a113b4d7-c198-49c0-a9ea-68b5e5fb4c63/US20110064811A1-20110317-D00002.png "Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
The present invention relates to solid state forms, for example, crystalline forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, pharmaceutical compositions thereof, and methods therewith.
![Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fca071a-314f-4377-9fc7-ac4cd3638424/US20100130547A1-20100527-D00000.png "Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide")
![Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fca071a-314f-4377-9fc7-ac4cd3638424/US20100130547A1-20100527-D00001.png "Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide")
![Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/7fca071a-314f-4377-9fc7-ac4cd3638424/US20100130547A1-20100527-D00002.png "Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
ActiveUS8410274B2Good physical and chemical stabilityPromote dissolutionBiocideSenses disorderFormamideOxoquinolines
![Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/dcede4dd-2f3e-4f55-87e4-8901c2ca1068/US08410274-20130402-D00001.png "Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/dcede4dd-2f3e-4f55-87e4-8901c2ca1068/US08410274-20130402-D00002.png "Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/dcede4dd-2f3e-4f55-87e4-8901c2ca1068/US08410274-20130402-D00003.png "Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Indazolecarboxamide derivatives for the treatment and prevention of malaria
Owner:SANOFI AVENTIS SA
Indazolecarboxamide derivatives for the treatment and prevention of malaria
The invention relates to methods of treating or preventing malaria which comprises administering to a patient in need thereof, an effective amount of a 1H-indazole-3-carboxamide derivative of general formula (I), in the form of a base or of an addition salt with an acid, or in the form of a hydrate or of a solvate of said base or acid addition salt.
Owner:SANOFI AVENTIS SA
Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
![Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/4baaf15e-fb3f-415d-8b4e-3918bdaf9203/US20130018071A1-20130117-D00001.png "Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/4baaf15e-fb3f-415d-8b4e-3918bdaf9203/US20130018071A1-20130117-D00002.png "Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/4baaf15e-fb3f-415d-8b4e-3918bdaf9203/US20130018071A1-20130117-D00003.png "Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide
![Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/8f255c1b-9c7e-42b7-b67c-69c9522637d2/US08389727-20130305-D00001.png "Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide")
![Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/8f255c1b-9c7e-42b7-b67c-69c9522637d2/US08389727-20130305-D00002.png "Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide")
![Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/8f255c1b-9c7e-42b7-b67c-69c9522637d2/US08389727-20130305-D00003.png "Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide")
Owner:VERTEX PHARMA INC
Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof
InactiveUS6849743B2High activity in inhibitionPrevent and reduce sizeBiocideOrganic compound preparationCombinatorial chemistryFormamide
The present invention is directed to an improved synthesis of clasto-lactacystin-β-lactone, and analogs thereof, that proceeds in fewer steps and in much greater overall yield than syntheses described in the prior art. The synthetic pathway relies upon a novel stereospecific synthesis of an oxazoline intermediate and a unique stereoselective addition of a formyl amide to the oxazoline. Also described are novel clasto-lactacystin-β-lactones, and analogs thereof and their use as proteasome inhibitors.
Owner:MILLENNIUM PHARMA INC
Pharmaceutical Composition and Administrations Thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.
Owner:VERTEX PHARMA INC
Azolecarboxamide herbicides
Compounds of Formula I, and their N-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation and R1a, R1b, R1c, R2a, R2b, R3, R4, R5, T, U, W, Y and Z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula I and a method for controlling undesired vegetation which involves contacting the vegetation or its environment with an effective amount of a compound of Formula I. Also disclosed are mixtures and compositions comprising a herbicidally effective amount of a compound of Formula Iz wherein J, R1a, R1b, R1c, R2a, R2b, R3, R4, R5, T, U, W, Y and Z are as defined in the disclosure; and an effective amount of another herbicide or herbicide safener. Also disclosed is a method for selectively controlling undesired vegetation in a crop that involves contacting the locus of a crop with an effective amount of a compound of Formula Iz and a effective amount of a safener.
Owner:EI DU PONT DE NEMOURS & CO
Natural insect and arthropod repellent
InactiveUS6306415B1Avoid damageSafe, long-lasting, effective and pleasantBiocideCosmetic preparationsCarboxylic acidStable fly
A topical insect repellent with extended duration of protection was obtained from mixtures of molecules based on two or more volatile repellent organic molecular species occurring naturally on the human skin surface. The novel repellent comprises mixtures of lower, intermediate, and higher volatility organic molecules. Active ingredients for formulations are obtained from homologous series of carboxylic acids, alcohols, ketones, and lactones which span a similar range of volatility and which occur naturally on the skin surface. Volatile silicone fluid imparts mildness and water repellency to the repellent formulations. The new natural repellent exhibits the longevity and repellency that is comparable to N,N-diethyl-m-toluamide (DEET), a synthetic compound employed in almost all commercial formulations, but the inventive natural repellent is more acceptable than DEET, which has an unpleasant odor and imparts a greasy feel to the skin. The inventive insect repellent, formulated in a volatile silicone fluid, was shown to repel and incapacitate stable flies. This finding demonstrated that repellency was not limited to mosquitoes, but extends to other biting flies or insects, thus demonstrating the utility of the novel insect repellent for protecting pets and livestock as well as humans.
Owner:STRATACOR
Crosslinkable macromers
Owner:SURMODICS INC
Novel 2-pyridinecarboxamide derivatives
The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I): [wherein X1 represents a nitrogen atom, sulfur atom, oxygen atom or the like; R1 represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R and R3 are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II) represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III) represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.
Owner:MSD KK
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
![Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/c2ad6d18-8f31-4c38-af24-c9d238ab7529/US20110230519A1-20110922-D00001.png "Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/c2ad6d18-8f31-4c38-af24-c9d238ab7529/US20110230519A1-20110922-D00002.png "Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
![Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/c2ad6d18-8f31-4c38-af24-c9d238ab7529/US20110230519A1-20110922-D00003.png "Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide")
Owner:VERTEX PHARMA INC
Crosslinkable macromers
InactiveUS6924370B2Improve performancePromote growthElectrotherapyDead plant preservationSolubilityFormamide
A crosslinkable macromer system and related methods of preparing the system and using the system in the form of a crosslinked matrix between a tissue site and an implant article such as a tissue implant or on the porous surface of a prosthetic device. The macromer system includes two or more polymer-pendent polymerizable groups and one or more initiator groups (e.g., polymer-pendent initiator groups). The polymerizable groups and the initiator group(s), when polymer-pendent, can be pendent on the same or different polymeric backbones. The macromer system provides advantages over the use of polymerizable macromers and separate, low molecular weight initiators, including advantages with respect to such properties as nontoxicity, efficiency, and solubility. A macromer system of the invention can be used as an interface between the tissue site and implant article in a manner sufficient to permit tissue growth through the crosslinked matrix and between the tissue site and implant. In a preferred embodiment, polymers with pendent polymerizable groups, for use in the macromer system, are prepared by reacting a polysaccharide polymer with a reactive moiety in an organic, polar solvent such as formamide.
Owner:SURMODICS INC
CGRP Antagonist Salt
InactiveUS20100286122A1Efficient synthesisEfficient preparationBiocideNervous disorderPotassiumFormamide
An efficient synthesis for the preparation of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, by coupling (3R,6S)-3-amino-6-(2,3-difluorophenyl)-1-(2,2,2-trifluoroethyl)azepan-2-one and 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride with 1,1′-carbonyldiimidazole (“CDI”) as carbonyl source; an efficient preparation of the potassium salt of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; efficient syntheses for the preparation of intermediates (3R,6S)-3-amino-6-(2,3-difluorophenyl)-1-(2,2,2-trifluoroethyl)azepan-2-one and 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride, and the potassium salt of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide including the potassium salt ethanolate and potassium salt hydrate.
Owner:MERCK SHARP & DOHME CORP
Coated ceramic catalyst supports and method
ActiveUS7166555B2Reduce penetrationReduce porosityOrganic-compounds/hydrides/coordination-complexes catalystsCatalyst activation/preparationPolyvinyl alcoholMetallurgy
Owner:CORNING INC
Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents
The present invention relates to a process for the preparation of novel pyrrolo [2,1-c][1,4]benzodiazepine hybrids useful as antitumour agents. This invention also relates to a process for the preparation of new pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential antitumour agents. More particularly, it provides a process for the preparation of 7-methoxy-8-[N-(1''-pyrenyl)-alkane-3'-carboxamide]-oxy-(11aS)-1,2,3,11a-tetraydro 5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one, with aliphatic chain length variation of these compounds and it also describes the DNA binding, anticancer (antitumour) activity. The structural formula of this novel pyrrolo[2,1-c][1,4]benzodiazepine is given below:
![Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/9e1c19a1-408f-4f53-81f3-2d2b401141b1/US06800622-20041005-C00001.png "Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents")
![Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/9e1c19a1-408f-4f53-81f3-2d2b401141b1/US06800622-20041005-C00002.png "Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents")
![Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents](https://images-eureka-patsnap-com.libproxy1.nus.edu.sg/patent_img/9e1c19a1-408f-4f53-81f3-2d2b401141b1/US06800622-20041005-C00003.png "Pyrene-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids useful as anti-cancer agents")
Owner:COUNCIL OF SCI & IND RES
Preparation method of vilazodone or its hydrochloride
The invention discloses a preparation method of vilazodone or its hydrochloride, which comprises the following steps: the compound of formula (I) is mixed with the compound of formula (II) 5-(1 -piperazinyl)-benzofuran-2-formamide reaction, then collect vilazodone shown in formula 1 from the reaction product; Gained vilazodone 1 is in a solvent, and hydrochloric acid is salified to prepare formula (A ) shown vilazodone hydrochloride. The present invention overcomes the defects and deficiencies in the existing preparation methods of vilazodone and its intermediates, is more suitable for the large-scale industrial preparation of vilazodone hydrochloride, has obvious creativity, and has a relatively large positive progress effect and practical application value. The reaction formula is as follows:
Owner:SHANGHAI INST OF PHARMA IND
Crosslinkable macromers
InactiveUS20060240072A1Increased toxicityImprove bindingBone implantAbsorbent padsSolubilityFormamide
A crosslinkable macromer system and related methods of preparing the system and using the system in the form of a crosslinked matrix between a tissue site and an implant article such as a tissue implant or on the porous surface of a prosthetic device. The macromer system includes two or more polymer-pendent polymerizable groups and one or more multifunctional initiator groups. The polymerizable groups and the initiator group(s), when polymer-pendent, can be pendent on the same or different polymeric backbones. The macromer system provides advantages over the use of polymerizable macromers and separate, low molecular weight initiators, including advantages with respect to such properties as nontoxicity, efficiency, and solubility. A macromer system of the invention can be used as an interface between the tissue site and implant article in a manner sufficient to permit tissue growth through the crosslinked matrix and between the tissue site and implant. In a preferred embodiment, polymers with pendent polymerizable groups, for use in the macromer system, are prepared by reacting a polysaccharide polymer with a reactive moiety in an organic, polar solvent such as formamide.
Owner:SURMODICS INC
Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof
Compounds of the formulawherein R1, R2, R3, R4, X and Y are as defined, which have a superior cGMP specific phosphodiesterase (PDE) inhibitory activity, and can be used as an agent for the treatment of cardiovascular diseases such as angina pectoris, heart failure, cardiac infarction, hypertension, arteriosclerosis, and the like; allergic diseases such as asthma, or disorders of male or female genital function and the like.
Owner:TAKEDA PHARMA CO LTD
Aluminum-doped zinc oxide film coating and nano-rod array material as well as preparation method thereof
InactiveCN101560059ALow resistivityHigh light transmittanceNanostructure manufactureZinc Acetate DihydrateSol-gel
The invention discloses an aluminum-doped zinc oxide film coating and nano-rod array material as well as a preparation method thereof. The aluminum-doped zinc oxide film coating and nano-rod array material comprises the components based on the weight percentage: 95-99% of zinc oxide and 1-5% of aluminum-doped quantity. The preparation method adopts a sol-gel method, zinc acetate and aluminium nitrate are added with organic solvent according to the proportion for heating under reflux; the mixed solution is then added with certain quantity of stabilizing agent for water bath heating at certain temperature and added with organic reagents such as absolute ethyl alcohol, methanamide or methanol and the like to prepare sol according to the need; after that, a spin coating method is adopted to form a film, and the aluminum-doped zinc oxide nano film coating material can be obtained by the processes such as drying, pretreating, repeatedly spin coating, annealing, secondary annealing under the atmosphere of hydrogen and nitrogen and the like; then, a hydrothermal method is adopted for preparing highly oriented aluminum-doped zinc oxide nano-rod and array thereof. The invention has high utilization rate of the raw materials, low cost and simplified preparation technique, and can control the performance and the particle size of the material from the molecular design level.
Owner:CENT SOUTH UNIV
Quaternary opioid carboxamides
ActiveUS20090197905A1Good to excellent peripheral opioid antagonism activityLess susceptibleBiocideNervous disorderSide effectMedicine
Owner:RENESSELAER POLYTECHNIC INST
Novel anthranilamide insecticides
This invention provides compounds of Formula I, N-oxides and suitable salts thereof wherein Y and V are each independently N or CR4a; W is N, CH or CR6; and R1 through R6, and n are as defined in the disclosure. This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula I, an N-oxide thereof or an agronomic or nonagronomic suitable salt of the compound and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, and optionally further comprising an effective amount of at least one additional biologically active compound or agent. Also disclosed are methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, an N-oxide thereof or an agronomic or nonagronomic suitable salt of the compound or with the composition described herein.
Owner:EI DU PONT DE NEMOURS & CO
Preparation method of metal-organic framework porous adsorption material for normal paraffin and isoparaffin adsorption separation
InactiveCN104549160AHigh purityReduce transition timeOther chemical processesAdsorption purification/separationN dimethylformamideReaction temperature
The invention relates to a preparation process of a metal-organic framework porous adsorption material for C4-C8 normal paraffin and isoparaffin adsorption separation. According to the preparation method of the synthesized metal-organic framework porous adsorption material, metal ion nitrate and an organic ligand are dissolved according to the mass ratio of 1:1-15 in a mixed solution of N,N-dimethylformamide and N,N-diethyl formamide; stirring is carried out for 0.5-12 h; reaction temperature is controlled to 80-250 DEG C, and reaction time is 12-120 h; and by a hydrothermal synthesis method, the metal-organic framework porous adsorption material is prepared. The material has characteristics as follows: specific surface area is large; pore structure height is ordered; pore size is controllable; surface potential energy is controllable; and adsorption capacity of normal paraffin is large. The material can selectively adsorb normal paraffin from mixed materials of normal paraffin and isoparaffin, has high selectivity and has a wide practical application prospect in normal paraffin and isoparaffin separation.
Owner:CHINA PETROLEUM & CHEM CORP +1
High flame retardancy type soft foam plastic insulation product and preparation method thereof
ActiveCN103102533AHigh oxygen indexImprove flame retardant performancePolyvinyl chloridePolyethylene glycol
The invention provides a high flame retardancy type soft foam plastic insulation product and a preparation method thereof. The product comprises the following components in parts by weight: 12 to 15 parts of nitrile rubber, 8 to 10 parts of talcum powder, 0.5 to 0.8 parts of polyethylene glycol, 0.2 to 0.4 parts of antiager 4020, 15 to 20 parts of chlorinated paraffin, 0.6 to 0.9 parts of paraffin, 1 to 2 parts of epoxidized soybean oil, 0.1 to 0.3 parts of antiager RD, 0.4 to 0.7 parts of carbon black, 7 to 10 parts of polrvinyl chloride, 26 to 36 parts of fire retardant based on the total amount, 2 to 5 parts of dioctyl ester, 8 to 12 parts of azodicarbonamide, 0.2 to 0.5 parts of stearic acid, 0.4 to 0.7 parts of zinc oxide, 0.4 to 0.7 parts of sulphur, and 1.3 to 1.8 parts of accelerant based on the total amount. By adopting the high flame retardancy type soft foam plastic insulation product, the technical problem that the oxygen index and the smoke density are mutually conflicted in the technological manufacture is solved, and the bottleneck due to mutual limitation is broken through.
Owner:HEBEI HUAMEI CHEM & BUILDING MATERIALS GRP
Ethylene propylene diene terpolymer sponge rubber and preparation method thereof
The invention provides an ethylene propylene diene terpolymer sponge rubber and a preparation method thereof, relating to a rubber and a preparation method thereof. The ethylene propylene diene terpolymer sponge rubber is prepared from ethylene propylene diene terpolymer, a foaming agent, a filling enhancer, a plasticizer, molecular sieve powder with a hygroscopic effect, a vulcanizing agent and a vulcanizing aid. The ethylene propylene diene terpolymer sponge rubber is characterized in that the molecular sieve powder is used for replacing traditional talc powder or calcium carbonate to be used as a filling agent, a foaming agent azobisformamide (AC) and a foaming agent 4,4'-oxy bis(benzenesulfonyl hydrazide) (OBSH) are combined and matched with an accelerant, and the decomposing rate of the foaming agent and the vulcanizing rate of the ethylene propylene diene terpolymer are matched, thus a microporous sponge rubber sealing product with a hygroscopic function is prepared under die pressing vulcanization conditions. The tensile strength, elongation percentage, stress at definite elongation, compression set and other indexes of the ethylene propylene diene terpolymer sponge rubber can meet the use performance requirements of sponge sealing strips; and at the same time, the sponge rubber has uniform foam pores, small density and hygroscopic function.
Owner:JINGDONG RUBBER
Preparation method of pimavanserin
The invention discloses a preparation method of pimavanserin. The method comprises the following two steps: firstly, 4-isobutoxy benzene methylamine and carbonyl diimidazole are subjected to acylation reaction to obtain N-(4-isobutoxy phenyl)-1H-imidazole-1-formamide, and the N-(4-isobutoxy phenyl)-1H-imidazole-1-formamide and N-(4-fluorophenyl)-1-methylpiperidine-4-amine are subjected to urea reaction, so as to obtain the pimavanserin. The prepared pimavanserin is good in quality and high in yield, the reagent toxicity is relatively low, the operation is simple and easy to control, and the pimavanserin is suitable for industrial production.
Owner:NKD PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com